Vir Biotechnology, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
Report From J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
Article By: Rod Raynovich Thursday, January 14, 2021 5:42 AM EST
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on specific companies and stocks in a series of posts.
In this article: ABT, BMY, GNMK, IBB, HOLX, PACB, XBI, ABBV, AXDX, GKOS, TDOC, VIR Also: AZN, GSK, MRNA, BNTX, JPM
Read
E US Stock Market Weekly Review Aug. 31- Sept. 4, 2020
Article By: Stavros Georgiadis Sunday, September 6, 2020 6:54 AM EST
After four weeks of consecutive gains, the US stock market declined with increased volatility, as September kicked in, a month which is considered to be a tough one for stocks historically.
In this article: KELYB, GOGO, TCON, VIR, KCAC, ADTX
Read
Vir Biotechnology Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Tuesday, July 7, 2020 3:11 PM EST
Vir Biotechnology, Inc., today announced the pricing of its previously announced underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $42.00 per share.
In this article: VIR
Read
Volatile Week For Coronavirus Stocks: COVID Vaccines Are In Focus
Article By: Rod Raynovich Sunday, June 28, 2020 1:41 PM EST
Friday was a risk-off day for biotech stocks as the XBI​ took a 3.28% hit on profit taking and concerns that the pandemic could drag on through the summer.
In this article: INO, NVAX, QDEL, XBI, MRNA, VIR, BNTX
Read
The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates
Article By: Benzinga Sunday, April 12, 2020 1:22 PM EST
Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19) impact.
In this article: ABT, JNJ, ALNY, GILD, ISRG, AMRN, AXSM, SCYX, ASND, URGN, ITRM, OVID, VIR
Read
Week In Review: CICC Capital Closes $229 Million China Fund For Biologics
Article By: ChinaBio® Today Saturday, February 29, 2020 1:50 PM EST
CICC Capital closed a $229 million investment fund for biologics, with investments coming mainly from Chinese organizations inside and outside the biopharma industry. Some of the money will go to companies making COVID-19 vaccines and therapies.
In this article: AZN, GSK, PFE, GILD, MRNA, BGNE, VIR
Read
Coronavirus Stocks
Article By: Zacks Investment Research Saturday, January 25, 2020 7:06 PM EST
This China originated virus is has now crossed international borders sparking concern this outbreak will become a pandemic. The stock market dropped 1% Friday due to fears of this outbreak, but some equities have been seeing massive fear gains.
In this article: APT, LAKE, VIR
Read
1 to 7 of 7 Posts